Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,138,749,234
+$9,911,059,154 QoQ
Shares Held
28,462,475
+8.1% QoQ
Ownership
3.02%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#6
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. LLY ranks #1 (45.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,138,749,234 | 28,462,475 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $24,227,690,080 | 26,341,031 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,642,566,885 | 25,721,670 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,443,092,556 | 24,171,812 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $19,979,176,944 | 25,629,773 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,512,557,584 | 28,468,668 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $23,573,211,456 | 30,535,248 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $29,268,285,931 | 33,036,420 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $30,319,384,450 | 33,488,021 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,514,804,582 | 34,082,478 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $19,146,252,223 | 32,845,420 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,288,856,832 | 32,187,472 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,381,741,573 | 32,798,289 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,991,938,721 | 32,007,276 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $12,339,954,410 | 33,730,468 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,688,866,158 | 33,056,645 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,517,912,904 | 32,439,666 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,032,307,393 | 31,540,690 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,440,670,817 | 30,557,783 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,205,389,670 | 31,185,413 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $7,080,361,718 | 30,848,561 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,763,797,727 | 30,852,145 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,327,544,959 | 25,631,041 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $4,419,735,691 | 29,859,044 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,924,102,483 | 29,992,097 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $3,889,332,312 | 28,037,286 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||